Related references
Note: Only part of the references are listed.Tissues and Tumor Microenvironment (TME) in 3D: Models to Shed Light on Immunosuppression in Cancer
Teresa Ho et al.
CELLS (2021)
Potential oncogenic roles of mutant-p53-derived exosomes in the tumor-host interaction of head and neck cancers
Etti Ester Azulay et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic
Eliran Kadosh et al.
NATURE (2020)
Tumor-infiltrating lymphocytes: Warriors fight against tumors powerfully
Baisheng Lin et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Tumor-Infiltrating Lymphocytes in the Checkpoint Inhibitor Era
Gerald P. Linette et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)
TP53 Mutations Promote Immunogenic Activity in Breast Cancer
Zhixian Liu et al.
JOURNAL OF ONCOLOGY (2019)
M2b macrophage polarization and its roles in diseases
Le-xun Wang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others
Kanaga Sabapathy et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
M2-macrophage infiltration and macrophage traits of tumor cells in urinary bladder cancer
Firas Aljabery et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
Tomer Cooks et al.
NATURE COMMUNICATIONS (2018)
Chemokine-Induced Macrophage Polarization in Inflammatory Conditions
Pieter Ruytinx et al.
FRONTIERS IN IMMUNOLOGY (2018)
The expression profile of p14, p53 and p21 in tumour cells is associated with disease-specific survival and the outcome of postoperative chemotherapy treatment in muscle-invasive bladder cancer
Firas Aljabery et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
Radio-guided sentinel lymph node detection and lymph node mapping in invasive urinary bladder cancer: a prospective clinical study
Firas Aljabery et al.
BJU INTERNATIONAL (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment
Staffan Jahnson et al.
SCANDINAVIAN JOURNAL OF UROLOGY (2016)
Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
Yoshihiro Komohara et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Modification of tumor cell exosome content by transfection with wt-p53 and microRNA-125b expressing plasmid DNA and its effect on macrophage polarization
M. Trivedi et al.
ONCOGENESIS (2016)
The biological complexity of urothelial carcinoma: Insights into carcinogenesis, targets and biomarkers of response to therapeutic approaches
Petros D. Grivas et al.
SEMINARS IN CANCER BIOLOGY (2015)
A unique role for p53 in the regulation of M2 macrophage polarization
L. Li et al.
CELL DEATH AND DIFFERENTIATION (2015)
p53 and NF-κB Coregulate Proinflammatory Gene Responses in Human Macrophages
Julie M. Lowe et al.
CANCER RESEARCH (2014)
Caught in the cross fire: p53 in inflammation
Tomer Cooks et al.
CARCINOGENESIS (2014)
Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors
Gottfrid Sjodahl et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis
Firas Abdollah et al.
CANCER EPIDEMIOLOGY (2013)
Non-Cell-Autonomous Tumor Suppression by p53
Amaia Lujambio et al.
CELL (2013)
p53 Status in Locally Advanced Bladder Cancer
Omer Dizdar et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection
Hui-Hui Lin et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
Share Paper
